True Concepts Medical Technologies
True Concepts Medical is a medical device innovation company dedicated to designing solutions that reduce human error and improve patient outcomes in critical areas such as sepsis and sudden cardiac arrest. Their devices are clinician-designed to enhance clinical workflow, safety, and efficiency, with a focus on saving lives and reducing healthcare costs.
Industries
Nr. of Employees
small (1-50)
True Concepts Medical Technologies
Patents
Products
D'VIA
A dual-chamber blood collection system that diverts the initial contaminated aliquot, isolates a defined volume of uncontaminated blood for culture, meters accurate volumes into culture bottles, and preserves diverted blood for additional biomarker testing.
Dual Chamber Syringe
A two-chamber syringe that sequentially delivers a drug dose followed immediately by a saline flush in a single-step operation to accelerate emergency medication delivery and reduce dosing errors.
D'VIA
A dual-chamber blood collection system that diverts the initial contaminated aliquot, isolates a defined volume of uncontaminated blood for culture, meters accurate volumes into culture bottles, and preserves diverted blood for additional biomarker testing.
Dual Chamber Syringe
A two-chamber syringe that sequentially delivers a drug dose followed immediately by a saline flush in a single-step operation to accelerate emergency medication delivery and reduce dosing errors.
Services
End-to-end development from clinician-identified problem through device design, validation, regulatory preparation and market entry.
End-to-end development from clinician-identified problem through device design, validation, regulatory preparation and market entry.
Expertise Areas
- Medical device design and engineering
- Sepsis diagnostics and blood culture contamination reduction
- Emergency medication delivery systems
- Regulatory compliance and quality systems for medical devices
Key Technologies
- Blood culture diversion systems
- Dual-chamber blood collection devices
- Dual-chamber drug-plus-flush syringes
- Volume-controlled blood dispensing
News & Updates
TCMT participated in MassChallenge 2023, showcasing their first product D’VIA™ and connecting with mentors and other startups.
Information about the Life Science Intelligence Emerging Medtech Summit in Dana Point, California, where TCMT will be present.
Awareness week focusing on the challenges faced by sepsis survivors, sharing stories and fostering community support.
The National Quality Forum endorsed CDC’s new blood culture contamination measure to improve sepsis testing accuracy.
2019 Most Promising Innovations for Quality and Safety
Recognition by QSEN Institute and other organizations for innovative solutions in healthcare.
Patents and Intellectual Property
30 U.S. and international patents granted and pending for D’VIA and Dual Chamber Syringe in 10 countries.
TCMT participated in MassChallenge 2023, showcasing their first product D’VIA™ and connecting with mentors and other startups.
Information about the Life Science Intelligence Emerging Medtech Summit in Dana Point, California, where TCMT will be present.
Awareness week focusing on the challenges faced by sepsis survivors, sharing stories and fostering community support.
The National Quality Forum endorsed CDC’s new blood culture contamination measure to improve sepsis testing accuracy.
2019 Most Promising Innovations for Quality and Safety
Recognition by QSEN Institute and other organizations for innovative solutions in healthcare.
Patents and Intellectual Property
30 U.S. and international patents granted and pending for D’VIA and Dual Chamber Syringe in 10 countries.